BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1372585)

  • 1. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells.
    Yajima S; Suzuki Y; Shimozawa N; Yamaguchi S; Orii T; Fujiki Y; Osumi T; Hashimoto T; Moser HW
    Hum Genet; 1992 Mar; 88(5):491-9. PubMed ID: 1372585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
    Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders.
    Slawecki ML; Dodt G; Steinberg S; Moser AB; Moser HW; Gould SJ
    J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
    Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H
    Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders].
    Suzuki Y
    No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytanic acid alpha-oxidation and complementation analysis of classical Refsum and peroxisomal disorders.
    Poll-The BT; Skjeldal OH; Stokke O; Poulos A; Demaugre F; Saudubray JM
    Hum Genet; 1989 Jan; 81(2):175-81. PubMed ID: 2463966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphometry of peroxisomes and immunolocalization of peroxisomal proteins in the liver of patients with generalised peroxisomal disorders.
    Hughes JL; Crane DI; Robertson E; Poulos A
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):459-68. PubMed ID: 7507276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis.
    Brul S; Westerveld A; Strijland A; Wanders RJ; Schram AW; Heymans HS; Schutgens RB; van den Bosch H; Tager JM
    J Clin Invest; 1988 Jun; 81(6):1710-5. PubMed ID: 2454948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human peroxisome-deficient disorders and pathogenic gene].
    Fujiki Y
    Rinsho Shinkeigaku; 1994 Dec; 34(12):1219-21. PubMed ID: 7539728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.
    Moser AB; Rasmussen M; Naidu S; Watkins PA; McGuinness M; Hajra AK; Chen G; Raymond G; Liu A; Gordon D
    J Pediatr; 1995 Jul; 127(1):13-22. PubMed ID: 7541833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome.
    Shimozawa N; Tsukamoto T; Suzuki Y; Orii T; Fujiki Y
    J Clin Invest; 1992 Nov; 90(5):1864-70. PubMed ID: 1430210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of hepatic peroxisomes and mitochondria in patients with peroxisomal disorders.
    Hughes JL; Poulos A; Robertson E; Chow CW; Sheffield LJ; Christodoulou J; Carter RF
    Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):255-64. PubMed ID: 1689088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and molecular aspects of peroxisome-deficient disorders].
    Suzuki Y; Shimozawa N; Orii T
    Nihon Rinsho; 1993 Sep; 51(9):2353-8. PubMed ID: 7692118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chinese hamster ovary cell mutants defective in peroxisome biogenesis. Comparison to Zellweger syndrome.
    Zoeller RA; Allen LA; Santos MJ; Lazarow PB; Hashimoto T; Tartakoff AM; Raetz CR
    J Biol Chem; 1989 Dec; 264(36):21872-8. PubMed ID: 2689450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ genetic complementation analysis of cells with generalized peroxisomal dysfunction.
    Singh AK; Kulvatunyou N; Singh I; Stanley WS
    Hum Hered; 1989; 39(5):298-301. PubMed ID: 2482247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation analysis of peroxisomal disorders and classical Refsum.
    Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
    Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
    [No Abstract]   [Full Text] [Related]  

  • 17. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy.
    Small GM; Santos MJ; Imanaka T; Poulos A; Danks DM; Moser HW; Lazarow PB
    J Inherit Metab Dis; 1988; 11(4):358-71. PubMed ID: 2468817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome assembly mutations in humans: structural heterogeneity in Zellweger syndrome.
    Santos MJ; Hoefler S; Moser AB; Moser HW; Lazarow PB
    J Cell Physiol; 1992 Apr; 151(1):103-12. PubMed ID: 1560037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect.
    Shimozawa N; Suzuki Y; Orii T; Moser A; Moser HW; Wanders RJ
    Am J Hum Genet; 1993 Apr; 52(4):843-4. PubMed ID: 7681622
    [No Abstract]   [Full Text] [Related]  

  • 20. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.